Safety and Efficacy of Neuroform for Treatment of Intracranial Aneurysms: A Prospective, Consecutive, French Multicentric Study

Article Figures & Data

Table 1:

Modified Rankin Scale scores preprocedure for 107 unruptured aneurysms

Modified Rankin Score (mRS)	n	%
0: No symptoms at all	84	78.5
1: No significant disability despite symptoms; able to carry out all usual duties and activities	14	13.1
2: Slight disability; unable to carry out all previous activities but able to look after own affairs without assistance	4	3.7
3: Moderate disability; requiring some help but able to walk without assistance	2	1.9
4: Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance	3	2.8

Table 2:

Aneurysm topography

Localization	n	%
Internal carotid artery (cavernous segment)	6	5.6
Internal carotid artery (ophthalmic segment)	30	28
Internal carotid artery (communicating segment)	3	2.8
Anterior choroidal artery	3	2.8
Middle cerebral artery	28	26.2
Pericallosal artery	2	1.9
Anterior communicating artery	8	7.5
Posterior communicating artery	16	15
Posterior cerebral artery	1	0.9
Superior cerebellar artery	1	0.9
Basilar tip	9	8.4
Total	107	100

Table 3:

Summary of the antiplatelet regimens for 107 patients

Antiplatelet	Preprocedure	Periprocedure	Postprocedure
Clopidogrel
No. patients (%)	98 (91.6)	29 (27.1)	102 (95.3)
Mean dose (mg)	204	159	76
Median (mg)	225	75	75
Range (mg)	75–600	75–600	75–150
Aspirin
No. patients (%)	45 (42.1)	65 (60.7)	97 (90.7)
Mean dose (mg)	158	245	159
Median (mg)	160	250	160
Range (mg)	75–250	150–500	75–250

Table 5:

Cross-table results of postprocedural occlusion and occlusion at 12–18 months

	Angiographic Results Follow-Up (12–18 months)			Total
	Complete Occlusion	Residual Neck	Residual Aneurysm	Total
Postoperative angiographic results
Complete occlusion	58^{^a}	3^{^c}	2^{^c}	63
Residual neck	7^{^b}	6^{^a}	4^{^c}	17
Residual aneurysm	4^{^b}	2^{^b}	7^{^a}	13
Total	69	11	13	93